Cromos Pharma, where the patients are

CROs/Service Providers

IMS Health files for IPO

Monday, January 6, 2014 03:02 PM

IMS Health, a global information and technology services company, has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

More... »

CRF Health eCOA webinar series

DaVita Clinical Research collaborates with Pacific Pharma Group

Monday, January 6, 2014 11:57 AM

DaVita Clinical Research (DCR), a specialty CRO with services in drug and device development, has formed a non-exclusive agreement with Pacific Pharma Group to provide consulting, program strategy and protocol design support for clinical pharmacology studies performed at DCR.

More... »

Kester Capital sells Chiltern

Thursday, January 2, 2014 10:54 AM

Kester Capital, the European private equity arm of Greenhill & Co., has sold its interest in Chiltern in a deal valuing the company at $223.4 million. The exit comes as Chiltern announces the consolidation of existing investors, led by Sir Douglas Myers. The transaction has generated a return of over two times capital and a 25% IRR for Kester Capital funds.

More... »

WCCT Global completes vaccine clinical trial unit

Thursday, January 2, 2014 10:39 AM

CRO WCCT Global has completed a specialized clinical research unit for vaccine clinical trials.

More... »

Cyprotex acquires CeeTox

Thursday, January 2, 2014 10:34 AM

Cyprotex, a specialist ADME-Tox CRO, has acquired CeeTox, a division of North American Science Associates. CeeTox, based in Kalamazoo, Mich., is a CRO specializing in the provision of in vitro toxicological assays and screening data, principally to the Cosmetic and Personal Care Industries. Founded in 2003, CeeTox was acquired in 2005 by NAMSA, a medical research organization supplying expert consulting, clinical and laboratory services to medical device, IVD and biologics manufacturers. NAMSA retains a license for applying CeeTox’s in vitro toxicology experience to medical device testing.

More... »

Report: Pay incentives lower at CROs than in other industries

Monday, December 16, 2013 02:30 PM

Employees at CROs receive lower annual and long-term incentives than their counterparts in other industries, according to the 15th annual CRO Industry Global Compensation and Turnover Survey, conducted by HR+Survey Solutions, a compensation consulting and research firm.

More... »

Bridgepoint Development Capital to acquire Quotient Clinical

Monday, December 16, 2013 02:26 PM

Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum. Employing over 200 people, Quotient Clinical has developed a platform which offers an integrated approach to formulation development, "real-time" drug product manufacturing and clinical testing. Using this platform has been proven to significantly reduce the time and cost of the early stage drug development process.

More... »

Venn Life Sciences acquires Medevol

Wednesday, December 11, 2013 11:23 AM

European CRO Venn Life Sciences has acquired Medevol, a CRO based in Northern Ireland, for a total maximum consideration of $1.1 million.

More... »

Algorithme Pharma, Hôpital Maisonneuve-Rosemont partner

Wednesday, December 11, 2013 11:19 AM

CRO Algorithme Pharma has partnered with Hôpital Maisonneuve-Rosemont (HMR). The HMR clinical research team includes over 60 clinicians and is supported by 75 employees and 75 graduate students and postgraduates. Together, they form an experienced network working in hematology, oncology, nephrology, ophthalmology and metabolic diseases.

More... »

Centro Ricerche Cliniche di Verona receives new EUCROF early phase quality mark

Wednesday, December 11, 2013 11:17 AM

Centro Ricerche Cliniche di Verona (CRC), an early phase CRO, has become the first organization to be accredited under a new scheme of quality certification conducted by the European CROs Federation (EUCROF).

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs